Indeed, the recently published MHC single nucleotide polymorphism studies in MS [19], SLE [96] and T1D [97] and the forthcoming IMAGEN (International Major Histocompatibility Complex and Autoimmunity Genetics Network) consortium data prove the utility of these experiments. The gene discussed is HLA-C; the disease is myeloid sarcoma.